BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8306813)

  • 1. Postantibiotic effect, and postantibiotic effect of subinhibitory concentrations, of sparfloxacin on gram-negative bacteria.
    Odenholt-Tornqvist I; Bengtsson S
    Chemotherapy; 1994; 40(1):30-6. PubMed ID: 8306813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.
    Odenholt-Tornqvist I
    J Antimicrob Chemother; 1993 Jun; 31(6):881-92. PubMed ID: 8360126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.
    Odenholt-Tornqvist I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1852-8. PubMed ID: 1329631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal kinetics and postantibiotic effect of sparfloxacin against selected species of respiratory pathogens.
    Speciale A; Blandino G; Nicolosi VM; Siracusa V; Caccamo F
    J Chemother; 1995 Dec; 7(6):530-4. PubMed ID: 8667038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postantibiotic effects and postantibiotic effects of subinhibitory levels of quinolines on Pseudomonas aeruginosa].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1996 May; 45(2):56-8. PubMed ID: 8756401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control-related effective regrowth time and post-antibiotic effect of meropenem on gram-negative bacteria studied by bioluminescence and viable counts.
    Hanberger H; Svensson E; Nilsson LE; Nilsson M
    J Antimicrob Chemother; 1995 May; 35(5):585-92. PubMed ID: 7592171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subinhibitory concentrations of moxifloxacin in an in-vitro dynamic model.
    Maggiolo F; Capra R; Bartoli A; Bottura P; Migliorino M; Suter F
    J Chemother; 2000 Apr; 12(2):129-33. PubMed ID: 10789551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase.
    Odenholt I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2522-6. PubMed ID: 9371360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro postantibiotic effect of sparfloxacin and ciprofloxacin against Pseudomonas aeruginosa and Enterococcus faecalis.
    Pastor A; Pemán J; Cantón E
    J Antimicrob Chemother; 1994 Nov; 34(5):679-85. PubMed ID: 7706163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin.
    Odenholt I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3352-6. PubMed ID: 14506057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
    Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1503-5. PubMed ID: 9624503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
    Hybenová D; Majtán V
    Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens.
    Zhao DH; Yu Y; Zhou YF; Shi W; Deng H; Liu YH
    Lett Appl Microbiol; 2014 Feb; 58(2):150-5. PubMed ID: 24117872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postantibiotic effects and postantibiotic sub-MIC effects of amoxicillin on Streptococcus gordonii and Streptococcus sanguis.
    Lee SY
    J Chemother; 2000 Oct; 12(5):379-84. PubMed ID: 11128556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of the new quinolone CI-960 (PD 127391) against clinical isolates at a major tertiary care center in Saudi Arabia.
    Qadri SM; Abo-Askar H; Ueno Y
    Chemotherapy; 1992; 38(2):92-8. PubMed ID: 1317281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-exposure effects of cefepime and cefpirome on isogenic Escherichia coli hosts producing SHV-extended-spectrum beta-lactamases.
    Bedenic B; Vranes J
    J Chemother; 2003 Aug; 15(4):342-9. PubMed ID: 12962362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.
    Piddock LJ; Zhu M
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2423-7. PubMed ID: 1666499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between the sensitivity of Pseudomonas aeruginosa and the post-antibiotic effect of sparfloxacin and ciprofloxacin].
    Pastor A; Cantón E; Pemán J
    Rev Esp Quimioter; 1998 Dec; 11(4):333-8. PubMed ID: 9990147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.